Top Clinical Trials companies in Canada by Goodwill

This ranking features the top 15 Clinical Trials companies in Canada ranked by Goodwill, totaling a Goodwill of USD 146.05 M, for February 07, 2025.
#
Name
Goodwill
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 60.24 M
Dec. 31, 2023 USD 4.02 0.45%

Canada

2
USD 47.81 M
Dec. 31, 2023 USD 3.17 -1.86%

Canada

3
USD 15.71 M
Dec. 31, 2023 USD 9.31 -2.03%

Canada

4
USD 12.02 M
Dec. 31, 2023 USD 14.60 -0.95%

Canada

5
USD 10.28 M
March 31, 2024 USD 2.13 -19.44%

Canada

6
USD 0.00
Dec. 31, 2023 USD 2.91 -1.79%

Canada

7
USD 0.00
Aug. 31, 2024 USD 1.89 1.61%

Canada

8
USD 0.00
Sept. 30, 2023 USD 1.91 1.06%

Canada

9
USD 0.00
Dec. 31, 2023 USD 6.18 -0.57%

Canada

10
USD 0.00
Dec. 31, 2023 USD 1.22 2.52%

Canada

11
USD 0.00
Nov. 30, 2023 USD 1.71 12.04%

Canada

12
USD 0.00
Dec. 31, 2023 USD 39.98 -1.21%

Canada

13
USD 0.00
Dec. 31, 2023 USD 0.95 7.20%

Canada

14
USD 0.00
Dec. 31, 2023 USD 7.95 -0.62%

Canada

15
USD 0.00
June 30, 2024 USD 3.13 -0.64%

Canada

Frequently Asked Questions
  • Which Clinical Trials company in Canada has the highest Goodwill ?

    The Clinical Trials company in Canada with the highest Goodwill is Knight Therapeutics Inc. (Toronto Stock Exchange: GUD.TO) at USD 60.24 M.

  • Which Clinical Trials company in Canada has the lowest Goodwill ?

    The Clinical Trials company in Canada with the lowest Goodwill is InMed Pharmaceuticals Inc. (NasdaqCM: INM) at USD 0.00.

SV Wall Street